Evidence map›Paper›PMID 31473079›Full record

Trial reportJournal of diabetes and its complications2019

Economic costs of implementing group interventions to reduce diabetes distress in adults with type 1 diabetes mellitus in the T1-REDEEM trial.

Martha Shumway, Lawrence Fisher, Danielle Hessler, Vicky Bowyer, William H Polonsky, Umesh Masharani

Open access · greenAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of diabetes and its complications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Martha ShumwayDepartment of Psychiatry, University of California, San Francisco, Box 0884, San Francisco, CA 94143-0884, USA. Electronic address: martha.shumway@ucsf.edu.
Lawrence FisherDepartment of Family and Community Medicine, University of California, San Francisco, Box 0900, San Francisco, CA 94143-0900, USA.
Danielle HesslerDepartment of Family and Community Medicine, University of California, San Francisco, Box 0900, San Francisco, CA 94143-0900, USA.
Vicky BowyerDepartment of Family and Community Medicine, University of California, San Francisco, Box 0900, San Francisco, CA 94143-0900, USA.
William H PolonskyBehavioral Diabetes Institute, 5405 Oberlin Drive #100, San Diego, CA 92121, USA.
Umesh MasharaniDepartment of Medicine, University of California, San Francisco, Box 1222, San Francisco, CA 94143-1222, USA.
University of California, San Francisco · US

Funding

NIDDK NIH HHS R01 DK094863
6 · The paper itself

Abstract

aimsThis study evaluated the implementation costs of two group interventions, one focused on diabetes education (KnowIt) and one focused directly on diabetes distress (OnTrack), that reduced diabetes distress and HbA1C in adults with poorly controlled type 1 diabetes (T1DM) in the T1-REDEEM trial.

methodsResources used to provide interventions were enumerated using activity-based micro-costing methods. Costs were assigned to resources in 2017 US dollars. US median wage and benefit rates were used to calculate costs of staff time. Cost per unit change was calculated for diabetes distress and HbA1C.

resultsFor both interventions, per participant implementation costs were approximately $250 and cost per 1.0 percentage point (11 mmol/mol) change in HbA1C was $1400. Cost per unit change in diabetes distress was $364 for KnowIt and $335 for OnTrack. No statistically significant differences in costs were observed.

conclusionsThis is the first study to examine the costs of implementing interventions targeting diabetes distress in the context of T1DM. Both interventions had per participant implementation costs in the lower end of the range of previously examined diabetes self-management interventions ($219 to $5390). These inventions and their costs merit further attention because reducing diabetes distress may impact long term T1DM outcomes. CLINICAL TRIALS REGISTRATION: ClinicalTrials.govNCT02175732.

Indexed as

Patient Education as TopicPsychological DistressPsychotherapy, GroupAdultAnxietyCost-Benefit AnalysisDepressionDiabetes Mellitus, Type 1Group ProcessesHealth Care CostsHumansImplementation ScienceMiddle AgedPatient Acceptance of Health CareSelf CareStress, PsychologicalCost analysisCostsPatient educationSelf-managementType 1 diabetes

Identifiers

PMID31473079
PMCPMC6823162
OpenAlexW2968641056

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.